IL41798A - Pyrrolidylidene-,piperidylidene-and hexahydroazepinylidene-ureas and their preparation - Google Patents
Pyrrolidylidene-,piperidylidene-and hexahydroazepinylidene-ureas and their preparationInfo
- Publication number
- IL41798A IL41798A IL7341798A IL4179873A IL41798A IL 41798 A IL41798 A IL 41798A IL 7341798 A IL7341798 A IL 7341798A IL 4179873 A IL4179873 A IL 4179873A IL 41798 A IL41798 A IL 41798A
- Authority
- IL
- Israel
- Prior art keywords
- reacting
- group
- preparing
- pyrrolidylidene
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/12—Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (1)
1. PROCESS CIA A process for preparing 1 chemical compounds selected from the group 2 consisting of pyrrolidylidene piperidylidene 3 hydroazepinylidene ureas having the and the therapeutically active acid addition salts n is the integer 2 or the group consisting 8 hydrogen and lo 9 is a member selected from the group consisting 10 of loweralkyl and benzyl 11 is member selected from the group consisting 12 hydrogen and and PROCESS CLAIMS Ar s a from the croup of and and and and trifluoro halophenyl and provided when said n is 2 or then said R is hydrogen and said is characterized by 6 reacting a compound of the formula 7 with a compound of the formula 8 erably i n a c PROCESS CLAIMS reacting a compound of the formula II with a compound of the formula 0 R2 preferably in a and if preparing a therapeutically active acid addition salt of the products of steps or A process for preparing according to claim characterized by reacting with phenylisocyanate A process for preparing phenylurea with A process for preparing urea according to claim characterized by reacting with CLAIMS 243 A process for preparing according to claim characterized reacting with fluorophenylisocyanate A process for preparing pyrrolidylidene according to claim characterized by reacting with A process for preparing according to claim by reacting A process for preparing pyrrolidylidene according to claim characterized by reacting with te A process for preparing according to claim characterized by reacting with A process for preparing pyrrolidylidene according to claim characterized by reacting with A process for preparing according characterized by reacting with A process for preparing according to claim characterized reacting with A process for preparing acc0rding to claim characterized by reacting with phenylisocyanate PROCES 243 A process for preparing according to claim characterized by reacting with methylphenylisocyanate A process for preparing according to claim characterized by reacting with A process for preparing according to claim characterized by reacting with A process for preparing according to claim characterized by reacting with process for preparing according to claim characterized by reacting with PRODUCT 19 Chemical selected from the group consisting of piperidylidene and hydroazepinylidene ureas having the PRODUCT CLAIMS Ar is a member selected from the group consisting of and and and and 20 21 trifluoro 22 halophenyl and 23 provided PRODUCT CLAIMS 243 is a selected from group i of hydrogen and 7 is a member selected from the group 8 loweralkyl and 9 a selected from the group consisting 10 of hydrogen and and 11 Ar is a member selected from the group consisting of and halpp enyl and t 15 and 19 arid 20 21 Chemical selected the consisting of pyrrolidylidene ureas having the and the therapeutically active acid addition salts wherein Ar is a member selected from the group consisting of and and and nit 22 A compound selected from the group consisting piperidylidene ureas having the r PRODUCT CLAIMS and the therapeutically active acid addition salts is lkyl is a from the group consisting of hydrogen and and Ar is a member selected from the group consistin of and and and and i halophenyl and A selected from the group consisting of hexahydroazepinylidene ureas havin and the is selected from the group consisting of hydrogen and and Ar is a member selected from the group consisting of and and cyanop and 24 25 26 27 28 pyrrolidylidene 4 32 pyrrolidylidene PRODUCT 33 34 35 36 40 243 PRODUCT CLAIMS 41 A central nervous system characterized by the fact that the active ingredient has the I 42 A process for preparing a compound of the formula substantially as hereinbefore and with reference to the accompanying 43 A compound of the formula I herein whenever prepared according to the process claimed in claim insufficientOCRQuality
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23581672A | 1972-03-17 | 1972-03-17 | |
US33584573A | 1973-02-26 | 1973-02-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL41798A0 IL41798A0 (en) | 1973-05-31 |
IL41798A true IL41798A (en) | 1976-04-30 |
Family
ID=26929245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL7341798A IL41798A (en) | 1972-03-17 | 1973-03-16 | Pyrrolidylidene-,piperidylidene-and hexahydroazepinylidene-ureas and their preparation |
Country Status (12)
Country | Link |
---|---|
AT (2) | AT323191B (en) |
CA (1) | CA950464A (en) |
CH (1) | CH578539A5 (en) |
CS (2) | CS179412B2 (en) |
DE (1) | DE2313257A1 (en) |
DK (1) | DK136715B (en) |
FI (1) | FI56831C (en) |
FR (1) | FR2181826B1 (en) |
GB (1) | GB1414048A (en) |
IL (1) | IL41798A (en) |
NL (1) | NL7303723A (en) |
NO (1) | NO140136C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ183570A (en) * | 1976-03-19 | 1979-06-08 | Mcneilab Inc | Heterocyclic guanidine derivatives, having anti-secretory and hypogliycaemic activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3717648A (en) * | 1970-10-21 | 1973-02-20 | Sterling Drug Inc | 1-phenyl-azacarbocyclic-2-imines |
-
1973
- 1973-03-15 GB GB1259773A patent/GB1414048A/en not_active Expired
- 1973-03-15 CH CH380773A patent/CH578539A5/xx not_active IP Right Cessation
- 1973-03-16 IL IL7341798A patent/IL41798A/en unknown
- 1973-03-16 AT AT235973A patent/AT323191B/en not_active IP Right Cessation
- 1973-03-16 DE DE2313257A patent/DE2313257A1/en not_active Withdrawn
- 1973-03-16 DK DK143773AA patent/DK136715B/en unknown
- 1973-03-16 AT AT521774A patent/AT323194B/en not_active IP Right Cessation
- 1973-03-16 CA CA166,285,A patent/CA950464A/en not_active Expired
- 1973-03-16 FR FR7309562A patent/FR2181826B1/fr not_active Expired
- 1973-03-16 NO NO1067/73A patent/NO140136C/en unknown
- 1973-03-16 NL NL7303723A patent/NL7303723A/xx not_active Application Discontinuation
- 1973-03-16 FI FI819/73A patent/FI56831C/en active
- 1973-03-19 CS CS7300001976A patent/CS179412B2/en unknown
- 1973-03-19 CS CS7500004295A patent/CS179444B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO140136B (en) | 1979-04-02 |
FI56831C (en) | 1980-04-10 |
CA950464A (en) | 1974-07-02 |
NL7303723A (en) | 1973-09-19 |
NO140136C (en) | 1979-07-11 |
CH578539A5 (en) | 1976-08-13 |
GB1414048A (en) | 1975-11-12 |
CS179412B2 (en) | 1977-10-31 |
DE2313257A1 (en) | 1973-10-04 |
FI56831B (en) | 1979-12-31 |
IL41798A0 (en) | 1973-05-31 |
AT323191B (en) | 1975-06-25 |
AT323194B (en) | 1975-06-25 |
FR2181826A1 (en) | 1973-12-07 |
DK136715C (en) | 1978-04-24 |
CS179444B2 (en) | 1977-10-31 |
DK136715B (en) | 1977-11-14 |
FR2181826B1 (en) | 1976-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1386566A (en) | Alpha-sulphobenzyl penicillin salts | |
GB1333471A (en) | Imidazoline derivatives and process for preparing the same | |
IL38972A (en) | Substituted phenyl alkanol derivatives,their preparation and compositions containing them | |
IE36383L (en) | Aryl guanidines | |
IE38373B1 (en) | Novel carbamic acid esters and their use as insecticides and acaricides | |
BE784245A (en) | PROCESS FOR THE PREPARATION OF ORGANIC MONO-AND POLYISOCYANATES FROM TRISUBSTITUTED UREA | |
IL41798A (en) | Pyrrolidylidene-,piperidylidene-and hexahydroazepinylidene-ureas and their preparation | |
MY7800145A (en) | Substituted pyrimidine thionothiolphosphoric acid esters, process for their preparation and their use as insecticides or acaricides | |
GB1142066A (en) | New diphenyl-ureas and process for preparing them | |
ES8105709A1 (en) | Intermediates for the preparation of thienamycin and process for preparing intermediates. | |
IE39551B1 (en) | New polyisocyanates and a process for their production | |
IL42384A (en) | N-benzhydryl-n'-p-hydroxybenzyl-piperazines and processes for their manufacture and pharmaceutical compositions containing them | |
IL42675A (en) | Cyclic amides of thiophosphoric acids,their manufacture and their use as nematocides,insecticides and acaricides | |
DE1959365B2 (en) | Basic N- [2- (2-phenylbicydo- (2i, l) -heptyl] carbamates | |
GB1422037A (en) | Process for preparing phosphorodithioic acid diesters | |
GB1194526A (en) | Pyrancarboxylic Acid Anilides, process for their manufacture and their use as Pesticides | |
IE42191L (en) | 7ó-methoxy cephalosporin compounds. | |
ES407722A1 (en) | Therapeutically active 2-aminoalkylthio-3H-1.5-benzodiazepines and process for preparing them | |
GB1237847A (en) | Hydrazino-pyrimidines | |
IE39191L (en) | Sulphoglycopeptide salts | |
ES8105316A1 (en) | Antibiotic crystalline epimer, its preparation and pharmaceutical composition containing it. | |
IL43235A (en) | Crystalline pivaloyloxymethyl d(-)-alpha-aminobenzylpenicillinate,its production and pharmaceutical compositions containing it | |
IE38183L (en) | Anhydro-4-fluorocytosine nucleosides | |
GB1208367A (en) | New aryl-sulfonyl ureas, processes for their production and medicaments comprising them | |
TH538A (en) | Preparation process 15- hydroxymi No-e-Homoe Bernendy Riveve |